Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Cumello JosephEVP & General Mgr. | Tax withholding | F | $203K 582 sh | Sep 22, 2026 |
| 8 | Kosaraju SheelaEVP & Chief Legal Officer | Tax withholding | F | $191K 549 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 8 | Kelleher Eric RobertSee Remarks | Open-market sale · 10b5-1 plan | SELL | $19K 100 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 7 | O'Toole Brian EDirector, CEO and President | Open-market sale · 10b5-1 plan | SELL | $458K 20.0K sh | Sep 22, 2026 traded Sep 21, 2026 |
| 6 | Brown HaydenDirector, President & CEO | Option exercise | M | — 28.7K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 6 | Gessert EricaChief Financial Officer | Option exercise | M | — 9,700 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 6 | Brown HaydenDirector, President & CEO | Option exercise | M | — 17.7K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 5 | Gage BrodieEVP & Chief Product & | Tax withholding | F | $154K 442 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Dageville BenoitDirector | Tax withholding | F | $178K 535 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 5 | Modi Rajeev A.SEE REMARKS | Grant or award | A | $1,477 66 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 5 | DiPerna DinoEVP & Chief R&D Officer | Tax withholding | F | $155K 444 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Kharsansky AlanChief Technology Officer | Option exercise | M | — 3,424 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Gage BrodieEVP & Chief Product & | Tax withholding | F | $233K 669 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Gage BrodieEVP & Chief Product & | Tax withholding | F | $135K 388 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | DiPerna DinoEVP & Chief R&D Officer | Tax withholding | F | $71K 204 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Gage BrodieEVP & Chief Product & | Tax withholding | F | $71K 204 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Sousa Mauad BrunoDirector | Derivative conversion | C | $140K 4,800 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 5 | Sousa Mauad BrunoDirector | Derivative conversion | C | $140K 1,600 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 5 | Beaulier Jonathan MeadChief Revenue Officer | Tax withholding | F | $23K 70 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 5 | Dageville BenoitDirector | Tax withholding | F | $85K 256 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 5 | DiPerna DinoEVP & Chief R&D Officer | Tax withholding | F | $86K 247 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | DiPerna DinoEVP & Chief R&D Officer | Tax withholding | F | $149K 428 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Gage BrodieEVP & Chief Product & | Tax withholding | F | $81K 231 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 4 | Offer OrChief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $271K 32.2K sh | Sep 22, 2026 traded Sep 21, 2026 |
| 4 | Offer OrChief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $309K 37.5K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion | C | — 62.5K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Brown HaydenDirector, President & CEO | Option exercise | M | — 28.7K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Coll Crespo BlasCHIEF MEDICAL OFFICER | Tax withholding · 10b5-1 plan | F | $124K 10.6K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Voss Capital, LP10% Owner | In-the-money exercise | X | — 1,000 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Brown HaydenDirector, President & CEO | Option exercise | M | — 17.7K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Chuong JamesChief Financial Officer | Grant or award | A | — 6,374 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 2 | Warren EricChief Commercial Officer | Option exercise · 10b5-1 plan | M | $98K 7,438 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 2 | Gessert EricaChief Financial Officer | Option exercise | M | — 9,700 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Gessert EricaChief Financial Officer | Option exercise | M | — 8,433 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 1 | Prahm JeremyChief Investment Officer | Open-market sale · 10b5-1 plan | SELL | $84K 6,000 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $286K 860 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 0 | Coll Crespo BlasCHIEF MEDICAL OFFICER | Derivative conversion · 10b5-1 plan | C | — 12.0K sh | Sep 22, 2026 traded Sep 21, 2026 |
| 0 | Slootman FrankDirector | Option exercise · 10b5-1 plan | M | — 197.2K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 0 | Slootman FrankDirector | Option exercise · 10b5-1 plan | M | — 102.8K sh | Sep 22, 2026 traded Sep 21, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $596K 1,793 sh | Sep 22, 2026 traded Sep 21, 2026 |